ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
The use of 17-hydroxyprogesterone as a biomarker in men seeking fertility
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 189338" data-attributes="member: 13851"><p><strong>Main Points:</strong></p><p></p><p>•<span style="color: rgb(184, 49, 47)"> <strong>Selective estrogen receptor modulators, hCG, and anastrozole inhibitors are used off-label to increase intratesticular testosterone, which is essential for spermatogenesis.</strong> </span></p><p></p><p>• <span style="color: rgb(184, 49, 47)"><strong>Short-acting testosterone preparations, such as Natesto intranasal gel, has been shown to increase serum testosterone levels while maintaining semen parameters in a clinical trial. The short-acting properties are hypothesized to have lesser effect on the hypothalamus-pituitary-gonadal </strong></span><strong><span style="color: rgb(0, 0, 0)">(HPG)</span><span style="color: rgb(184, 49, 47)"> axis than traditional long-acting testosterone therapy. </span></strong></p><p></p><p>• <span style="color: rgb(0, 0, 0)"><strong>17-OHP </strong></span><span style="color: rgb(184, 49, 47)"><strong>is a biomarker for intratesticular testosterone, and its levels can be used to differentiate between men with hypogonadism needing improvement versus those who need to maintain their semen parameters.</strong></span></p></blockquote><p></p>
[QUOTE="madman, post: 189338, member: 13851"] [B]Main Points:[/B] •[COLOR=rgb(184, 49, 47)] [B]Selective estrogen receptor modulators, hCG, and anastrozole inhibitors are used off-label to increase intratesticular testosterone, which is essential for spermatogenesis.[/B] [/COLOR] • [COLOR=rgb(184, 49, 47)][B]Short-acting testosterone preparations, such as Natesto intranasal gel, has been shown to increase serum testosterone levels while maintaining semen parameters in a clinical trial. The short-acting properties are hypothesized to have lesser effect on the hypothalamus-pituitary-gonadal [/B][/COLOR][B][COLOR=rgb(0, 0, 0)](HPG)[/COLOR][COLOR=rgb(184, 49, 47)] axis than traditional long-acting testosterone therapy. [/COLOR][/B] • [COLOR=rgb(0, 0, 0)][B]17-OHP [/B][/COLOR][COLOR=rgb(184, 49, 47)][B]is a biomarker for intratesticular testosterone, and its levels can be used to differentiate between men with hypogonadism needing improvement versus those who need to maintain their semen parameters.[/B][/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
The use of 17-hydroxyprogesterone as a biomarker in men seeking fertility
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top